Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.20 PLN
211.77 M PLN
4.17 B PLN
45.40 M
About SOPHARMA AD BGN1
Sector
CEO
Ognian Ivanov Donev
Headquarters
Sofia
Website
Founded
1933
ISIN
BG11SOSOBT18
FIGI
BBG002976FB8
Sopharma AD engages in the provision of pharmaceutical business. Its operations include production and marketing of medical products, medicinal substances as well as dosage forms. It also involved in research, engineering, and implementation activities in the field of phytochemistry, chemistry, and pharmacy. The firm offers dermatological products, gastroenterological, as well as psychoneurological, antiallergic and others. The company was founded in 1933 and is headquartered in Sofia, Bulgaria.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SPH is 13.95 PLN — it has increased by 6.90% in the past 24 hours. Watch SOPHARMA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange SOPHARMA stocks are traded under the ticker SPH.
SPH stock has risen by 12.05% compared to the previous week, the month change is a 4.89% rise, over the last year SOPHARMA has showed a −15.45% decrease.
Today SOPHARMA has the market capitalization of 2.13 B, it has decreased by −0.41% over the last week.
Yes, you can track SOPHARMA financials in yearly and quarterly reports right on TradingView.
SOPHARMA is going to release the next earnings report on Nov 29, 2024. Keep track of upcoming events with our Earnings Calendar.
SPH net income for the last quarter is 35.62 M PLN, while the quarter before that showed 65.27 M PLN of net income which accounts for −45.43% change. Track more SOPHARMA financial stats to get the full picture.
SOPHARMA dividend yield was 17.31% in 2023, and payout ratio reached 135.90%. The year before the numbers were 13.45% and 102.49% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SOPHARMA EBITDA is 274.78 M PLN, and current EBITDA margin is 8.05%. See more stats in SOPHARMA financial statements.
Like other stocks, SPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SOPHARMA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SOPHARMA technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SOPHARMA stock shows the strong buy signal. See more of SOPHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.